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Endoplasmic Reticulum Stress in Retinal Vascular
Degeneration: Protective Role of Resveratrol
Chuanzhou Li,1 Leilei Wang,1 Kun Huang,2,3 and Ling Zheng1
PURPOSE. Endoplasmic reticulum (ER) stress has been demon-
strated to contribute to neurodegeneration in multiple ocular
diseases. However, whether ER stress can induce vascular
degeneration in the retina remains unknown. We investigated
the possible role of ER stress in retinal vascular degeneration in
vivo, and the effects of resveratrol on tunicamycin and ischemia
and reperfusion (I/R)-induced retinal vascular degeneration.
METHODS. Different dosages of tunicamycin, an ER stress
inducer, were injected into the vitreous of mouse eyes. Retinal
I/R injury was induced by elevating the intraocular pressure for
60 minutes followed by reperfusion in mice. Two dosages of
resveratrol (5 and 25 mg/kg body weight per day) were
administrated 2 days before retinal I/R injury, while 100 lM
resveratrol were injected into the vitreous together with
tunicamycin. Formation of acellular capillaries was assessed 7
days after I/R injury and tunicamycin injection, while cell bodies
in ganglion cell layer and brain-specific homeobox/POU domain
protein 3A (Brn3a) staining on retinal flat-mounts were analyzed
4 days after I/R injury. ER stress markers, including eukaryotic
initiation factor 2a (eIF2a), CCAAT enhancer-binding protein
homologous protein (CHOP), immunoglobulin binding protein
(Bip), inositol requiring enzyme 1a (IRE1a), C-jun N-terminal
kinase (JNK)1/2 and Xbp1 splicing, were examined by RT-PCR,
or Western blots or immunostaining from retinas 1 or 2 days
after tunicamycin injection and I/R injury.
RESULTS. Tunicamycin caused ER stress and capillary degener-
ation in vivo, both of which were inhibited by resveratrol.
Pretreatment of high dosage of resveratrol also significantly
inhibited retinal I/R injury-induced capillary degeneration;
however, neither of the dosages prevented the injury-induced
neurodegeneration. Levels of CHOP, phosphorylated eIF2a,
IRE1a, phosphorylated JNK1/2, Xbp1 splicing and Bip were
elevated after I/R injury. High dosage of resveratrol pretreat-
ment inhibited the injury-induced up-regulation of eIF2a-CHOP
and IRE1a-XBP1 pathways.
CONCLUSIONS. ER stress is an important contributor to vascular
degeneration in retina. Resveratrol suppresses I/R injury and
tunicamycin-induced vascular degeneration by inhibiting ER
stress. (Invest Ophthalmol Vis Sci. 2012;53:3241–3249) DOI:
10.1167/iovs.11-8406
Retinal ischemia is one of the causative factors in variousocular diseases, including acute close-angle glaucoma and
diabetic retinopathy.1 Vascular and neuronal degeneration
observed in these diseases are the key histological hall-markers
that contribute to retinal dysfunction and vision loss in
patients.2–5 Retinal ischemia and reperfusion (I/R) injury is a
commonly used in vivo model to mimic neuronal and vascular
degeneration.4,6,7 Through this model, the mechanisms under-
lying these degenerations and the therapies preventing the
degenerations are studied.
One mechanism that contributes to the development of
neuronal degeneration in the retina is endoplasmic reticulum
(ER) stress. Upon accumulation of unfolded or misfolded
proteins, ER activates three branches of adaptive responses to
maintain cellular homeostasis and promote cell survival (see
reviews8,9). However, when the protein folding ability cannot
match the demand, ER stress is triggered and ER stress-
dependent apoptotic pathway is evoked.10,11 Elevation of ER
stress has been found in multiple animal models of retinal
diseases, including retinitis pigmentosa,12 glaucoma,13,14 and
diabetic retinopathy.15–17 The critical role of ER stress in
neurodegeneration in the retina also is demonstrated. Retinal
neurodegeneration, which was characterized by ganglion cell
loss and reduction of retinal thickness, has been observed after
intravitreal injection of ER stress inducer, such as tunicamy-
cin.18,19 Mice that are deficient in CCAAT enhancer-binding
protein homologous protein (CHOP), a transcription factor
mediating ER stress-dependent cell death, are resistant to N-
methyl-D-aspartic acid (NMDA)-induced retinal neurodegener-
ation.20 However, whether ER stress also contributes to
vascular degeneration in the retina is not known yet.
Resveratrol (trans-3,5,4 0-trihydroxystilbene), abundantly
found in grape skins,21 is a natural polyphenolic phytoalexin
with multiple bioactivities, including anti-oxidative22,23 and
anti-inflammatory24,25 effects. The protective effects of resver-
atrol in several ocular diseases, including light/oxygen-induced
retinopathy,26,27 endotoxin-induced uveitis,24 and diabetic
retinopathy,28 have been demonstrated. However, the informa-
tion on whether resveratrol could elicit protective effects on
retinal I/R-induced neurovascular degeneration is lacking.
We investigated ER stress inducer tunicamycin-induced
retinal vascular degeneration. The roles of resveratrol on
tunicamycin or retinal I/R-induced ER stress and retinal
vascular degeneration were evaluated. The results demonstrat-
ed that intravitreal injection of tunicamycin triggered ER stress
in whole retina and retinal vasculature, and subsequent-
induced capillary degeneration. Resveratrol inhibited tunica-
mycin and retinal I/R-induced capillary degeneration and
overexpression of ER stress makers. Our findings uncovered
a possible role of ER stress in retinal vascular degeneration, and
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C57BL/6 mice were obtained from Wuhan University Animal Labora-
tory, and housed in ventilated microisolater cages with free access to
water and food. All procedures involving the animals conformed to the
Association for Research in Vision and Ophthalmology (ARVO)
Statement for the Use of Animals in Ophthalmic and Vision Research,
and approved by the Committee on Ethics in the Care and Use of
Laboratory Animals of Wuhan University.
Retinal I/R Model and Resveratrol Administration
Retinal I/R was induced as previously reported.4,7 Briefly, after pupil
dilation, the anterior chamber of one eye in the mouse was cannulated
with a 33-gauge needle connected to a reservoir containing 0.9% NaCl.
Pressure in the eye was increased to 80–90 mmHg with a pressure infuser
(Infu-surg; Ethox Corp., Buffalo, NY). The duration of ischemia was 60
minutes. Retinal ischemia was confirmed by whitening of the iris and the
fundus under microscopic observation. After ischemia, the needle was
withdrawn and retinal circulation was reflowed. The other non-injured
eye of the same animal served as the control. A sham operation without
elevation of the pressure was done in some mouse eyes for comparison
with the non-injured ones. The results demonstrated that the ER stress
markers were expressed similarly in the sham operated retinas compared
to that in the non-injured retinas (Figs. S1A, S1B, http://www.iovs.org/
lookup/suppl/doi:10.1167/iovs.11-8406/-/DCSupplemental). Two days
before I/R injury, mice were pretreated with resveratrol (TCM Institute of
Chinese Materia Medica, Nanjing, China) in diets at dosages of 5 mg/kg
body weight (BW, low) and 25 mg/kg BW (high) per day. Retinas or
eyeballs of different groups were collected 3 hours, and 1, 4, and 7 days
after the injury for different analyses.
Tunicamycin Injection and Resveratrol
Administration
Tunicamycin (Alexis Biochemicals, San Diego, CA) was dissolved in
dimethylsulfoxide. Different dosages (0.1, 1, and 1.5 lg) of tunicamy-
cin were injected into the vitreous of mouse eyes after anesthetization,
and dimethylsulfoxide was injected as vehicle. As for resveratrol
treatment in this model, 100 lM resveratrol together with 0.1 lg
tunicamycin were injected into the vitreous. Retinas were harvested 1,
2, and 7 days after injection for different analyses.
Examination of Capillary Degeneration
Retinal vasculatures were isolated and quantitated as we reported
previously.4 Briefly, seven days after retinal I/R injury, pure retinal
vasculatures were isolated with a trypsin digestion manner. Isolated
vascular trees were stained with PAS and hematoxylin (PASH) for light
microscopy examination (200· magnification). Acellular (degenerate)
capillaries were identified as capillary-sized vessel tubes without nuclei
along their length, and quantitated and reported as number per square
millimeter of retinal area.
CHOP Immunofluorescence Staining on Retinal
Vasculatures
One day after retinal I/R injury or two days after tunicamycin injection,
eyeballs were enucleated and fixed in 4% formalin for 30 minutes.
Retinas then were isolated and washed with distilled water, followed by
digestion with 0.3% trypsin solution (Becton, Dickinson and Company,
Sparks, MD) for 3 minutes. Vasculatures were isolated carefully and
mounted onto slides. After permeabilization with 2% Triton X-100
(Amresco, Solon, OH), vasculatures were blocked with 5% BSA
(Amresco) and incubated with anti-CHOP (1:100 dilution, Santa Cruz,
CA) at 48C overnight. After extensive washing, vasculatures were
incubated with tetramethyl rhodamine iso-thiocyanate (TRITC)-labeled
anti-rabbit IgG (1:200 dilution; Dako, Denmark) for 1 hour at room
temperature. Anti-fading mounting solution containing DAPI (Beyotime
Biotech, Jiangsu, China) was added to the vasculatures, and images
were taken under the fluorescence microscopy. Negative control was
set up in parallel without applying primary antibody.
Morphologic Analysis and Quantitation of Cell
Bodies in Retinal Ganglion Cell Layer (GCL)
Four days after retinal I/R injury, eyeballs routinely were fixed,
embedded, cut, and stained with PASH. No retinal detachment was
observed on retinal sections of any experimental groups. The nuclei in
GCL (not including nuclei in the vessels) were counted. The result was
reported as number of nuclei in GCL per 250 lm of retinal surface as
reported previously.4,7
Brain-Specific Homeobox/POU Domain Protein 3A
(Brn3a) Immunofluorescence Staining
Four days after retinal I/R injury, retinal flat-mounts were freshly
isolated. After brief fixation in 4% formalin at room temperature, flat-
mounts were washed and treated with 2% Triton X-100 for 15 minutes,
then the immunostaining was performed using MOM kit (Vector
Laboratory, Burlingame, CA) with anti-Brn3a (1:100 dilution; Millipore,
Temecula, CA) and Alexa Fluor 488 labeled anti-mouse IgG (1:300
dilution; Invitrogen, Carlsbad, CA). After extensive washing, anti-fading
mounting solution containing DAPI (Beyotime Biotech) was added to
the samples. Images were taken under confocal microscope (Olympus,
FV1000) at multiple magnifications (40·, 100·, and 600·). Brn3aþ
cells in 20–30 different areas (600· magnification) of each retina were
counted and reported per square millimeter of retinal area.
RNA Isolation and RT-PCR
Total RNA was isolated from retina using RNAiso Plus (TaKaRa
Biotechnology, Dalian, China). Total RNA (1 lg) was reverse
transcribed into cDNA using M-MLV first strand synthesis system
(Invitrogen). The abundance of specific gene transcripts was assessed
by PCR. The primer sequences were listed in supplementary Table S1
(http://www.iovs.org/lookup/suppl/doi:10.1167/iovs.11-8406/-/
DCSupplemental). PCR products were separated by electrophoresis
using 1.5% agarose gels, and images were photographed by Molecular
Imager Gel Doc XR (Bio-Rad, Hercules, CA). Band density was
quantified using Quantity One 1-D Analysis Software (Bio-Rad). mRNA
levels were quantitated first against 18S rRNA levels in the same
sample, then normalized to non-injured group, which was set up as 1-
fold, with the exception that Xbp1 splicing was reported as the ratio of
spliced Xbp1(Xbp1s)/total Xbp1(Xbp1t).
Western Blot Analysis
Retinas were isolated and sonicated in RIPA buffer (Beyotime Biotech,
China). A total of 20–40 lg proteins per sample were separated by SDS-
PAGE and electroblotted onto PVDF membrane (Millipore). After
blocking, antibodies for p-eIF2a (CST, Danvers, MA), total-eIF2a (CST),
CHOP (Epitomics, Burlingame, CA), Immunoglobulin binding protein
(Bip; BD Transduction Laboratories, Franklin Lakes, NJ), inositol
requiring enzyme 1a (IRE1a; CST), phospho-C-jun N-terminal kinase
(JNK)1/2 (CST), total-JNK1/2 (CST), and b-actin (Sigma, St. Louis, MO)
were applied overnight at 48C. All blots were washed and incubated
with respective secondary antibody (Bio-Rad). Protein bands detected
by the antibodies were visualized by ECL reagent (Millipore) following
exposure on X-OMAT film. Protein expression levels were quantitated
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by the Quantity One 1-D Analysis Software (Bio-Rad) as we reported
previously.4,7 The protein levels, except for the phosphorylated
proteins, first were quantitated relative to b-actin in the same sample,
and then the relative protein expression levels in different groups were
normalized to the non-injured group, which set up as 1-fold. The levels
of the phosphorylated proteins were quantitated first relative to their
corresponding total protein levels in the same sample, and then the
relative phosphorylated protein expression levels in different groups
were normalized to the non-injured group, which was set up as 1-fold.
Statistical Analysis
All results were expressed as the mean 6 SD. Data were analyzed by
the nonparametric Kruskal-Wallis test followed by the Mann-Whitney U
test. Differences were considered statistically significant when P <




Vascular Degeneration in the Retina
Morphology of the vascular tree for the vehicle-injected retinas
was as normal as that for the non-injected retinas (data not
shown). However, seven days after tunicamycin injection, there
was a dramatic increase in formation of completed degenerated
capillaries (acellular capillaries), and ongoing degenerating cap-
illaries (condensed and fragmental-like nuclei within capillary
tubes) in the tunicamycin-injected retinas (Fig. 1A). In retinas
injected with 0.1, 1, and 1.5 lg tunicamycin, there were 32.7 6
11.9, 121.8 6 17.7, and 190.0 6 34.9 acellular capillaries per
mm2 retina, compared to 3.0 6 0.4 acellular capillaries per
mm2 in the vehicle injected retinas (P ¼ 0.01, Fig. 1B).
Moreover, 100 lM resveratrol significantly inhibited the
formation of acellular capillary induced by 0.1 lg tunicamycin
(P < 0.01). No significant differences in the formation of
acellular capillaries were found between vehicle-injected
retinas and non-injected retinas (Fig. 1B).
Resveratrol Inhibits Retinal I/R-Induced Vascular
Degeneration
Morphology of acellular capillaries after tunicamycin injection
was similar to the capillary degeneration found after retinal I/R
injury as we reported previously.4,7 Since resveratrol has been
reported to have vascular protective effects on retinal neovas-
cularization,29 the possible effect of resveratrol in vascular
degeneration after retinal I/R injury was investigated. Seven days
after injury, there was a significant increase in the formation of
acellular capillaries in I/R-injured retinas compared to that in
non-injured retinas (Fig. 2, P < 0.01), while there was no
significant difference in the number of degenerated capillaries
between non-injured and sham operated retinas (Fig. S1C,
http://www.iovs.org/lookup/suppl/doi:10.1167/iovs.11-8406/
-/DCSupplemental). Resveratrol administration (25 mg/kg BW/
day) significantly inhibited I/R injury-induced acellular capillary
formation compared to I/R-injured groups (P< 0.01). However,
low dosage resveratrol administration (5 mg/kg BW/day)
showed no effects on I/R injury-induced acellular capillary
formation.
Resveratrol Does Not Prevent Retinal I/R-Induced
Neuronal Cell Loss
Neuronal degeneration is another I/R-induced pathological
change besides capillary degeneration in the retina. Effects of
resveratrol on retinal I/R-induced neuronal cell loss were
evaluated by two different methods. Consistent with our
previous observations,4,7 four days after retinal I/R injury there
was a significant cell loss in GCL in I/R-injured retinas
compared to that in non-injured retinas (P < 0.01, Figs. 3A,
3B), while there was a similar cell number in GCL between
non-injured and sham-operated retinas (Fig. S1D, http://www.
iovs .org/ lookup/suppl/doi :10.1167/ iovs .11 -8406/ - /
DCSupplemental). However, pre-treatment of neither high nor
FIGURE 1. ER stress induces vascular degeneration in the retina. (A)
Representative images of retinal vasculatures seven days after
intravitreal injection of vehicle and 1.5 lg tunicamycin. (B) Quantita-
tive results of retinas treated with different dosages of tunicamycin, and
0.1 lg tunicamycin together with 100 lM resveratrol. n ¼ 4–6 per
group; C, non-injured retinas; Vehicle, retinas with vehicle injection;
Tunicamycin, retinas with tunicamycin injection. Arrowheads indicate
capillary with condensed nuclei inside. Arrows indicate acellular
capillaries. **P ¼ 0.01 compared to vehicle retinas. ##P < 0.01
compared to 0.1 lg tunicamycin-injected retinas. Scale bar represents
20 lm.
FIGURE 2. Resveratrol inhibits retinal I/R injury-induced vascular
degeneration. Quantitative results of acellular capillary formation were
shown seven days after retinal I/R injury. n ¼ 5–7 per group; I/R, I/R-
injured retinas; I/RþRSV(L), I/R-injured retinas with low dosage of
resveratrol treatment; I/RþRSV(H), I/R-injured retinas with high dosage
of resveratrol treatment; n.s., no significant difference.
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low dosage of resveratrol significantly inhibited I/R-induced
cell loss in GCL (Figs. 3A, 3B).
To confirm the effect of resveratrol on retinal I/R-induced
neurodegeneration, a specific retinal ganglion cell marker was
used. Brn3a is a transcription factor expressed specifically in
the nuclei of ganglion cells.30 Representative images of Brn3a
immunostaining of each group on retinal flat-mounts with
different magnifications were shown in Figure 3C (40· and
100·) and Figure S2 (600·, http://www.iovs.org/lookup/
suppl/doi:10.1167/iovs.11-8406/-/DCSupplemental). Quantita-
tive results demonstrated that the number of Brn3aþ cells
declined from 1914 6 196 cells in the non-injured group to
652 6 269 cells in the I/R-injured group per mm2 retinal area
(P < 0.01, Fig. 3D). Consistent with the result of cell number
counting in GCL, high dosage of resveratrol did not rescue I/R-
induced ganglion cell loss (702 6 187 Brn3aþ cells per mm2
retinal area, Fig. 3D).
Resveratrol Inhibits Retinal I/R-Induced Up-
Regulation of Eukaryotic Translational Initiation
Factor 2a (eIF2a)-CHOP Branch of ER Stress
Effects of resveratrol on ER stress were investigated further
after retinal I/R injury. Prolonged activation of ER stress results
in phosphorylation of eIF2a, which leads to induction of
CHOP, which initiates the ER stress-dependent apoptosis.8 The
mRNA and protein levels of CHOP were examined three hours
and one day after retinal I/R injury. Similar CHOP and p-eIF2a/
t-eIF2a levels were found in the injured retinas compared to
those in the non-injured retinas three hours after the injury
(Figs. S3A, S3B, http://www.iovs.org/lookup/suppl/doi:10.
1167/iovs.11-8406/-/DCSupplemental). However, the tran-
script level of Chop was increased mildly one day after retinal
I/R injury (P ¼ 0.08, Figs. 4A, 4B). In addition to mRNA level,
protein level of CHOP was 8-fold increased one day after retinal
I/R injury (P < 0.05, Fig. 4B). Furthermore, p-eIF2a, the
upstream factor that induces CHOP elevation, also was
increased significantly 5.3-fold one day after I/R injury (P <
0.05, Fig. 4B). All these changes were inhibited significantly by
high dosage of resveratrol pretreatment (P < 0.05, Figs. 4A,
4B). There was no difference in the total eIF2a level among the
experimental groups.
To clarify whether resveratrol affects ER stress on vascular
part of the retina, CHOP expression on retinal vasculatures of
different experimental groups was evaluated. We observed
elevated CHOP expression in the nuclei of vascular cells one
day after I/R injury, and this injury-induced vascular CHOP
overexpression was inhibited significantly by the pretreatment
high dosage of resveratrol (Fig. 4C).
Resveratrol Inhibits Retinal I/R-Induced IRE1a Up-
Regulation and Xbp1 Splicing
IER1a, another ER stress sensor localized on ER membrane, also
was analyzed. Although its level was not changed three hours
after the injury (Figs. S3A, S3B, http://www.iovs.org/lookup/
suppl/doi:10.1167/iovs.11-8406/-/DCSupplemental), an 8.1-fold
FIGURE 3. Resveratrol does not prevent retinal I/R injury-induced neurodegeneration. Four days after retinal I/R injury, number of cell bodies and
Brn3aþ cells were quantitated. (A) Representative images of PASH-stained retinal sections. Scale bar represents 20 lm. (B) Quantitative results of cell
bodies in GCL. (C) Representative images of Brn3a-stained retinal ganglion cells (green) on retinal flat-mounts. (A, B) 40·; (C, D) 100·; scale bars
represent 100 lm. (D) Quantitative results of Brn3a-stained cells on retinal flat-mounts. n¼ 7–9 per group; IPL, inner plexiform layer; INL, inner
nuclear layer; OPL, outer plexiform layer; ONL, outer nuclear layer.
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up-regulation of IER1a was triggered one day after I/R injury (P
< 0.05). Pretreatment of high dosage of resveratrol inhibited
significantly the injury-induced IRE1a overexpression (P < 0.05;
Figs. 5A, 5B). No difference was found in the total JNK1/2 levels
among the experimental groups one day after the injury.
However, one day after retinal I/R injury, a 3.6-fold increase in
phosphorylation level of JNK1/2 was observed (P< 0.05), while
resveratrol treatment did not inhibit this alternation.
Another possible downstream target of IRE1a activation,
Xbp1 splicing, was investigated. Xbp1 splicing, shown as the
ratio of Xbp1s/Xbp1t, was increased significantly one day after
I/R injury (P < 0.05, Figs. 5C, 5D). Pretreatment of high dosage
of resveratrol inhibited significantly the I/R injury-induced
Xbp1 splicing (P < 0.05, Figs. 5C, 5D).
Resveratrol Inhibits Retinal I/R-Induced
Overexpression of Bip
Bip is a molecular chaperone that modulates ER homeostasis
and helps protein refolding under stressed conditions.8 Its
protein level was increased mildly three hours after I/R (P ¼
0.08; Figs. S3A, S3B, http://www.iovs.org/lookup/suppl/doi:10.
1167/iovs.11-8406/-/DCSupplemental), the mRNA and protein
levels of Bip also were elevated one day after the injury (P <
0.05 and P¼ 0.08, respectively, Figs. 6A, 6B), and pretreatment
of high dosage resveratrol inhibited the injury-induced increase
in Bip mRNA level (P < 0.05) but not the protein level.
Resveratrol Inhibits Tunicamycin-Induced ER
Stress in the Retina
ER stress markers also were investigated in the retinas after
tunicamycin injection. RT-PCR results showed significantly
increased mRNA levels of ER stress markers, including Chop,
growth arrest and DNA damage-inducible protein 34
(Gadd34), Bip, heat shock protein 70 (Hsp70) and protein
disulfide isomerase (Pdi), in tunicamycin injected retinas (Fig.
S4A, http://www.iovs.org/lookup/suppl/doi:10.1167/iovs.
11-8406/-/DCSupplemental). Moreover, CHOP expression was
up-regulated in retinal vasculatures after tunicamycin injection
(Fig. S4B, http://www.iovs.org/lookup/suppl/doi:10.1167/
FIGURE 4. Resveratrol inhibits retinal I/R-induced activation of eIF2a-CHOP pathway. (A) Representative images of mRNA levels of Chop and 18S
rRNA (left panel) and the quantitative results (right panel) of different experimental groups. (B) Representative Western blots of p-eIF2a, total
eIF2a, CHOP, and b-actin (left panel), and the densitometric quantitative results (right panel) of different experimental groups. (C) Representative
images of CHOP staining (red) and DAPI staining (blue) on retinal vasculatures of different experimental groups. n ¼ 4–5 per group; *P < 0.05,
compared with non-injured retinas; §P¼0.08, compared with non-injured retinas; #P < 0.05, compared with I/R-injured retinas; scale bar represents
20 lm.
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iovs.11-8406/-/DCSupplemental). Western blots demonstrated
that 0.1 lg tunicamycin injection triggered significant overex-
pression of ER stress markers (CHOP, IRE1a, Bip) compared to
vehicle-injected retinas, and these increases were inhibited
significantly by resveratrol treatment (Fig. 7).
DISCUSSION
Neuronal and vascular cells are two major targets for retinal
damages in various ocular diseases. Neuronal and vascular
degeneration has been observed in retinal I/R injury mod-
els.4,6,7 Several mechanisms through which retinal I/R injury
contributes to neurodegeneration have been demonstrat-
ed.6,31–33 However, investigations on the underlying mecha-
nisms of I/R-induced vascular degeneration are lacking. In our
study, we demonstrated that tunicamycin injection and retinal
I/R injury could induce prolonged ER stress and acellular
capillary formation in vivo, and these alternations can be
inhibited dramatically by administration of resveratrol, suggest-
ing ER stress might be one contributor to vascular dysfunction
after retinal injury.
FIGURE 5. Resveratrol inhibits retinal I/R injury-induced IRE1a-XBP1 up-regulation. (A) Representative Western blots of IRE1a, p-JNK1/2, and total
JNK1/2 of different experimental groups. (B) Densitometric quantitative results of IRE1alpha and JNK1/2 activation. (C) Representative images of
mRNA levels of Xbp1s, Xbp1t, and 18S rRNA of different experimental groups. (D) Densitometric quantitative results of Xbp1 splicing. n¼4–5 per
group; *P < 0.05 compared with non-injured retinas, #P < 0.05 compared with I/R-injured retinas.
FIGURE 6. Resveratrol inhibits retinal I/R-induced increase of Bip transcription. (A) Representative images of mRNA levels of Bip and 18S rRNA
(upper panel) and the quantitative results (bottom panel) of different experimental groups. (B) Representative Western blots of Bip and b-actin
(upper panel), and the densitometric quantitative results (bottom panel) of different experimental groups. n¼4–5 per group; *P < 0.05, compared
with non-injured retinas; §P¼ 0.08, compared with non-injured retinas; #P < 0.05, compared with I/R-injured retinas.
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As an important cell type for normal retinal functions,
capillary cells can be triggered to death by severe ER stress in
vitro. CHOP protein are over-expressed in human retinal
capillary endothelial cells when challenged with ER stress
inducer or high glucose.34,35 Glucose deprivation also induces
overexpressions of CHOP and Bip in cultured rat retinal
capillary pericytes.36 However, in vivo data that links ER stress
to capillary cell death is missing. Our study demonstrated that
tunicamycin could dramatically induce formation of retinal
acellular capillary in a dose-dependent manner. Resveratrol
treatment significantly suppressed ER stress inducer-induced
acellular capillary formation. To our knowledge, this is the first
in vivo evidence showing that ER stress contributes to vascular
degeneration. However, whether ER stress factors have the
casual roles in I/R-induced capillary degeneration still is
unclear, and additional experiments that use endothelial cell-
specific CHOP knockout mice will be of future interest to
understand this issue better.
Involvements of ER stress in retinal diseases have been
demonstrated under multiple insults, including NMDA, ER
stress inducers, and I/R injury. These insults can trigger CHOP
induction, and cause retinal cell death and neurodegenera-
tion.18–20,37,38 In the chronic glaucoma model caused by
cauterizing episcleral veins, elevated CHOP expression and
subsequent retinal ganglion cell loss are demonstrated.14
Furthermore, retinal detachment induces significant increases
in CHOP and Bip expression levels, and retinal cell death.39 In
addition, I/R injury induced by central retinal artery occlusion
also causes an increase in ER stress-related markers, including
IRE1a and phosphorylated JNK1/2 in GCL.13 Activation of ER
stress not only is associated with retinal diseases, but also can
be a causative factor in the development of neurodegeneration
in the retina, since intravitreal injection of ER stress inducer,
such as tunicamycin, induces rapid retinal neurodegenera-
tion.18,19 Bip inducer inhibits the CHOP overexpression and,
thus, attenuates neurodegeneration in retina injuries induced
by NMDA and tunicamycin.19 Consistent with this, NMDA-
induced neurodegeneration is reduced in the mice lacking
CHOP.20 Activation of ER stress also was found in our study
using a high ocular pressure-induced I/R injury model, as
demonstrated by the significant increase in CHOP, p-eIF2a, Bip,
Xbp1 splicing and IRE1a overexpression and JNK1/2 activation
(Figs. 4–6).
The rationale for using resveratrol in our study is due to its
vascular protective effects, which have been studied in some
ocular diseases.24,29 In the endotoxin-induced uveitis model,
resveratrol administration leads to suppression of leukocyte
adhesion on the retinal vasculature by its anti-oxidative and
anti-inflammatory effects in a dose-dependent manner.24 Oral
administration of resveratrol also inhibits the retinal neo-
vascularization via inhibition of vascular endothelial growth
factor in Vldlr-/- mice,29 the mice with very low-density
lipoprotein receptor (VLDLR) mutant that have pathologic
features similar to macular telangiectasia.40 In our study,
resveratrol attenuates tunicamycin and I/R injury-induced
vascular degeneration (Figs. 1, 2), and a direct effect of
resveratrol on I/R-induced vascular CHOP overexpression also
is demonstrated (Fig. 4C), which is consistent with the vascular
protective roles of resveratrol.
The effects of resveratrol on ER stress are controversial
based on several in vitro studies. After 24 hours of incubation,
treatments with 10–100 lM resveratrol have been shown to
cause apoptosis, and induce overexpression of CHOP and Bip
in cancer cell lines.41–43 In contrast, other investigators have
demonstrated that in mouse embryonic fibroblasts co-treated
with tunicamycin for 6 hours, treatment with 10 lM resveratrol
inhibits significantly tunicamycin-induced CHOP and Bip
overexpression.44 However, to our knowledge, the effects of
resveratrol on ER stress in rodent models were unclear. In our
study, resveratrol inhibited significantly tunicamycin and
retinal I/R injury-induced up-regulation of ER stress markers,
including CHOP and IRE1a (Figs. 4, 5, 7). Moreover, retinal I/R
and tunicamycin-induced CHOP up-regulation in vascular cells
as well as capillary degeneration were blocked by resveratrol
treatment, suggesting ER stress might be a direct link between
I/R injury and the following capillary degeneration. Therefore,
resveratrol probably protects vasculature from degeneration
via attenuating ER stress pathways on retinal vessels after I/R
injury.
Resveratrol has been reported to have retinal neuroprotec-
tive effects. Resveratrol pretreatment at a dosage of 50 mg/kg
BW for 5 days prevents light-induced retinal neurodegenera-
tion.26 Treating the diabetic mice with resveratrol at a dosage of
20 mg/kg BW for 4 weeks inhibits neuronal apoptosis in the
retina via stimulating the activity of Ca2þ/calmodulin-dependent
protein kinase II.28 However, in our study, neither 5 nor 25 mg/
kg BW per day of resveratrol showed protective effects on
neurodegeneration after retinal I/R, as indicated by two
different methods (Fig. 3). This difference may be due to, but
not limited to, the different dosages of resveratrol and/or the
different durations of resveratrol exposure that were used.
Under our experimental conditions, the fact that resveratrol
inhibits the cell death of retinal capillary cells but not the
neuronal cells, at least, suggests vascular and neuronal elements
in the retina may be targeted differently by resveratrol.
FIGURE 7. Resveratrol inhibits tunicamycin-induced increase in ER
stress markers. Representative Western blots of CHOP, IRE1a, Bip, and
b-actin of different experimental groups were shown.
FIGURE 8. Possible mechanism of the protective effects of resveratrol
on retinal I/R injury and tunicamycin-induced vascular degeneration.
O-, inhibition by resveratrol.
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In summary, our study suggested that ER stress contributes
to retinal capillary degeneration in vivo. We demonstrated that
retinal I/R injury and tunicamycin trigger ER stress activation
and subsequent vascular degeneration. Resveratrol suppresses
tunicamycin and I/R injury-induced ER stress via inhibition of
expressions of CHOP and IRE1a, thus resulting in protection
against the injury-induced capillary degeneration (Fig. 8). Our
study revealed a possible role of ER stress in the development
of capillary degeneration, and suggested that resveratrol could
be a potential drug candidate for vascular dysfunction in the
retina.
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